C3.ai Investors Sue Over Alleged False Statements and Reduced Guidance

C3.ai investors with substantial losses have an opportunity to lead a class action lawsuit against the company and its executives, alleging violations of the Securities Exchange Act of 1934. The lawsuit claims that C3.ai created a false impression of growth and earnings potential while relying heavily on CEO Thomas M. Siebel's health. After disappointing financial results and reduced guidance, C3.ai's stock price fell 25%. Lead plaintiff motions must be filed by October 21, 2025.

Title: C3.ai Investors Seek Justice in Class Action Lawsuit

C3.ai investors with substantial losses have an opportunity to lead a class action lawsuit against the company and its executives, alleging violations of the Securities Exchange Act of 1934. The lawsuit claims that C3.ai created a false impression of growth and earnings potential while relying heavily on CEO Thomas M. Siebel's health. After disappointing financial results and reduced guidance, C3.ai's stock price fell 25%. Lead plaintiff motions must be filed by October 21, 2025.

The class action lawsuit, captioned Liggett v. C3.ai, Inc., No. 25-cv-07129 (N.D. Cal.), seeks to represent purchasers or acquirers of C3.ai, Inc. (NYSE: AI) securities and charges C3.ai and certain of C3.ai's top executives with violations of the Securities Exchange Act of 1934. The lawsuit alleges that defendants created the false impression that they possessed reliable information pertaining to C3.ai's projected revenue outlook and anticipated growth while also minimizing risk to C3.ai's profitability from defendant CEO Thomas M. Siebel's health concerns [1].

On August 8, 2025, C3.ai announced disappointing preliminary financial results for the first quarter of fiscal year 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing its poor sales results and lowered guidance on "the reorganization with new leadership" and the health ailments of its CEO. On this news, the price of C3.ai stock fell more than 25% [1].

The class action lawsuit further alleges that throughout the class period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) the health of C3.ai’s Chief Executive Officer was materially impairing the Company’s ability to close deals; (2) management was unable or otherwise ineffectual in mitigating the impact of the CEO’s health on business operations; and (3) as a result, C3.ai’s ability to execute on its profit and growth potential was significantly compromised [2].

Investors who purchased C3.ai securities between February 26, 2025, and August 8, 2025, are encouraged to contact the law firms representing them in this case. The Schall Law Firm, Robbins Geller Rudman & Dowd LLP, and Bronstein, Gewirtz & Grossman, LLC are among the firms handling this case [1, 2, 3].

The lead plaintiff process allows any investor who purchased or acquired C3.ai securities during the Class Period to seek appointment as lead plaintiff in the C3.ai class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the C3.ai class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the C3.ai class action lawsuit [1].

Investors who wish to review a copy of the Complaint can visit the firm’s site or contact the law firms involved. There is no cost to investors, as the firms represent investors on a contingency fee basis [1, 2, 3].

References
[1] https://www.barchart.com/story/news/34367254/c3-ai-investor-alert-c3-ai-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-c3-ai-class-action-lawsuit
[2] https://www.globenewswire.com/news-release/2025/08/25/3138833/9788/en/AI-INVESTOR-ALERT-Bronstein-Gewirtz-Grossman-LLC-Announces-that-C3-ai-Inc-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit.html
[3] https://www.marketscreener.com/news/ai-investors-have-opportunity-to-lead-c3-ai-inc-securities-fraud-lawsuit-with-the-schall-law-firm-ce7c50d8dd88f22d